Clinical Trials Directory

Trials / Unknown

UnknownNCT05986357

The Relation of High Sensitivity C Reactive Protein and Total Leucocytic Count Levels in Threatened Abortion

The Relation Between Maternal Serum High Sensitivity C Reactive Protein and Total and Differential Leucocytic Count Levels in Healthy Pregnant Women With Threatened Abortion and the Outcome of Pregnancy

Status
Unknown
Phase
Study type
Observational
Enrollment
240 (estimated)
Sponsor
Beni-Suef University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

to identify the relation between maternal serum high sensitivity C reactive protein and total and differential leucocytic count values in healthy pregnant women with threatened abortion and the outcome of pregnancy

Detailed description

observational prospective cohort research will be pregnant women attending to obstetrics and gynecology department of University Hospital. After enrollment, participants will be divided into two groups: * Study group: had 120 healthy women presenting with threatened miscarriage. * Control group: had 120 healthy women with an uncomplicated single pregnancy. informed permission will be obtained. All cases subjected to the following: taking complete history, General examination, Special investigations including Obstetric ultrasonography for assessment of gestational age, and exclusion of congenital anomalies or multi-fetal gestation. Laboratory investigations including Estimation of the complete blood picture (CBC), Highly sensitive CRP (HS-CRP) single measurement, Women over 1st trimester abdominal ultrasonographic examination (6-13weeks) using Toshiba with transabdominal transducer probe frequency of 7 MHz to evaluate the following data: Measuring of the fetal crown-rump length (CRL) done to confirm the fetal gestational age and the viability of the fetus. Gestational age will be calculated from the beginning of the last regular menstrual cycle. Women who had hormone therapy or progesterone supplements, as well as pregnancies with a discrepancy between LMP and crown rump length of more than three days, were excluded from the research. Pregnant women will be under close follow up every 2 weeks by: Obstetric U/S, Measure blood pressure and inform us if severe bleeding occurs.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTmaternal serum C reactive proteinmaternal serum high sensitivity C reactive protein
DIAGNOSTIC_TESTtotal leucocytic count levelstotal leucocytic count levels
DIAGNOSTIC_TESTdifferential leucocytic count levelsdifferential leucocytic count levels

Timeline

Start date
2023-07-30
Primary completion
2023-10-30
Completion
2023-10-30
First posted
2023-08-14
Last updated
2023-08-14

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05986357. Inclusion in this directory is not an endorsement.